Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Parkinson's Disease

Free Subscription 11.05.2026 4 Ann Neurol 1 Brain Res 1 Exp Neurol 5 Mov Disord 2 Neurobiol Dis 1 Neurologia (Engl Ed) 2 Neurology 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. CHIU SY, Wang WE, Chen R, DeSimone JC, et al
   Diffusion MRI and alpha-Synuclein Seed Amplification Status in Parkinson's Disease.
   Ann Neurol. 2026 May 7. doi: 10.1002/ana.78252.
   PubMed         Abstract available
   
   
2. MAREK K, Tropea TF
   Future Directions: The Parkinson's Precision Medicine Initiative.
   Ann Neurol. 2026 May 6. doi: 10.1002/ana.78244.
   PubMed        
   
   
3. CHAHINE LM, Alcalay RN, Brown EG, Chowdhury S, et al
   Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers Initiative.
   Ann Neurol. 2026 May 6. doi: 10.1002/ana.78249.
   PubMed         Abstract available
   
   
4. MAREK K, Chowdhury S, Tropea TF
   From Parkinson's Progression Markers Initiative to Parkinson's Precision Medicine Initiative: Still PPMI.
   Ann Neurol. 2026 May 5. doi: 10.1002/ana.78242.
   PubMed         Abstract available
   
   

   
   Brain Res

5. GOCK N, Kim G, Morin T, Young MA, et al
   DJ-1 deficiency in SH-SY5Y cells reveals dysregulated networks of genes and pathways involved in neuronal function and disease.
   Brain Res. 2026;1884:150322.
   PubMed         Abstract available
   
   

   
   Exp Neurol

6. DELONCLE R
   Conjecture for a free radical epimerization process in Alzheimer, Parkinson, Lewy body, amyotrophic lateral sclerosis, progressive Supranuclear Palsy and Creutzfeldt Jakob diseases.
   Exp Neurol. 2026 May 5:115812. doi: 10.1016/j.expneurol.2026.115812.
   PubMed         Abstract available
   
   

   
   Mov Disord

7. VERED D, Katzir Z, Grosbard ID, Thaler A, et al
   Electroencephalography-Based Clustering Reveals Robust Neurophysiological Subtypes in Parkinson's Disease.
   Mov Disord. 2026 May 6. doi: 10.1002/mds.70348.
   PubMed         Abstract available
   
   
8. CURY RG, Pavese N
   From Motor Effectors to Action Networks: SCAN Reshapes Parkinson's Disease Pathophysiology.
   Mov Disord. 2026 May 5. doi: 10.1002/mds.70347.
   PubMed        
   
   
9. PERCETTI M, Yahya V, Di Fonzo A, Monfrini E, et al
   Rethinking Mitochondrial Parkinson's Disease in the alpha-Synuclein Seed Amplification Assays Era.
   Mov Disord. 2026 May 3. doi: 10.1002/mds.70325.
   PubMed        
   
   
10. FABBRI M, Rascol O
    Neurology Under Fire: What About Parkinson's Disease in Wartime?
    Mov Disord. 2026 May 1. doi: 10.1002/mds.70350.
    PubMed        
    
    
11. CAMASTRA C, Buonocore J, Augimeri A, Calomino C, et al
    A Brainstem Radiomics Framework to Distinguish Progressive Supranuclear Palsy from Parkinson's Disease.
    Mov Disord. 2026 May 1. doi: 10.1002/mds.70334.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

12. JIN H, Meng L, Yulug B, Altay O, et al
    Machine learning based multi-omics analysis reveals key molecular determinants of Parkinson's disease severity.
    Neurobiol Dis. 2026;225:107424.
    PubMed         Abstract available
    
    
13. SERPA RO, Tufano E, Connor JR
    Reimagining the contribution of iron in Parkinson's disease.
    Neurobiol Dis. 2026 May 5:107434. doi: 10.1016/j.nbd.2026.107434.
    PubMed         Abstract available
    
    

    
    Neurologia (Engl Ed)

14. MOLINATTI F, De Gracia L, Oliva A
    Descriptive analysis of mortality due to Parkinson's disease and Alzheimer disease in Argentina.
    Neurologia (Engl Ed). 2026 May 1:502084. doi: 10.1016/j.nrleng.2026.502084.
    PubMed         Abstract available
    
    

    
    Neurology

15. TAMAKOSHI D, Hiraga K, Katsuno M
    Risk Is Not Destiny: Unmasked Penetrance of Parkinson Disease in Gaucher Disease.
    Neurology. 2026;106:e218074.
    PubMed        
    
    
16. ALCALAY RN, Mistry P, Di Fonzo A, Batista JL, et al
    Age-Specific Parkinson Disease Risk in Gaucher Disease Type 1: Data From the ICGG Gaucher Registry.
    Neurology. 2026;106:e214986.
    PubMed         Abstract available
    
    

    
    PLoS One

17. ALMOHIZA MA, Reddy RS
    Sensorimotor integration and functional mobility in early-stage Parkinson's disease: A cross-sectional study using clinically feasible assessments.
    PLoS One. 2026;21:e0348668.
    PubMed         Abstract available
    
    
18. GIL JY, Min KH, Kim JH, Park JH, et al
    Risk of Parkinson's disease in patients with schizophrenia: Impact of antipsychotic medication use.
    PLoS One. 2026;21:e0346233.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum